The FDA issued its initial Emergency Use Authorization for the Janssen (Johnson & Johnson) COVID-19 vaccine on Saturday February 27, 2021. . Cap Color: Orange (requires dilution) Expiry: The expiration date for the Pfizer-BioNTech COVID-19 vaccine for children ages 5-11 (orange cap) is NOT printed on the vaccine vial. The information available covers all COVID-19 vaccines including the Australian manufactured AstraZeneca COVID-19 vaccine. Pfizer and Moderna are two-dose vaccines, while J&J is one dose. Contents of the pack and other information. Data.CDC.gov. Access the expiration date by scanning the QR code located on the vaccine carton. If received at 2C to 8C, they should be stored at 2C to 8C. reference number. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Every person who gets the COVID-19 vaccine will receive a vaccination card at the time of their first dose. Espaol | Other Languages. 50 mcg/0.25 mL for booster dose adults 18+ (existing product), drawn from same vial as primary series. Saving Lives, Protecting People, (Click on a column heading to sort table accordingly), Public Health Information Network (PHIN) Vocabulary Access and Distribution System (VADS), National Center for Immunization and Respiratory Diseases, Core Data Elements For IIS Functional Standards v4.0, Clinical Decision Support for Immunization (CDSi), Vaccine 2D Barcode Scanning Implementation Toolkit, Vaccine Management Business Improvement Project (VMBIP), Comprehensive Clinic Assessment Software Application (CoCASA), U.S. Department of Health & Human Services, Centers for Disease Control and Prevention. Thawed vaccine cannot be refrozen. Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) is authorized for emergency use in individuals 5 years of age and older as a single booster dose administered at least 2 months after either: completion of primary vaccination with any authorized or approved COVID-19 vaccine, or receipt of the most . Batch release assessment is a critical part of the regulatory oversight of vaccine quality. As the expiration date approaches, contact the manufacturer to determine if it has been extended. Select up to three search categories and corresponding keywords using the fields to the right. CDC Pfizer-BioNTech COVID-19 Vaccine: Storage and Handling Summary (cdc.gov)FDA EUA Fact Sheet for Providers. Vaccine expires 18 months after the manufacture date. Only bivalent booster should be administered. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, for intramuscular use, 100 mcg/0.5 mL for adult 18+ (Same formulation and concentration as EUA product). I verify that Im in the U.S. and agree to receive communication from the AMA or third parties on behalf of AMA. 7`xk j "d%%%%`2sA09!--psT(r9e"GQ(r9:_E9+]P+{W]wE = FOi4x= FOi4xX,2H}6i[}oim ~pi>_ ?# After dilution, the vial should be held between 2C to 25C (35F to 77F). You can review and change the way we collect information below. Follow good vaccine storage and practices by outlined by the. This technology is designed primarily to help immunization providers record information about the VIS as is required by the National Childhood Vaccine Injury Act (NCVIA). Based on the shelf life currently approved in United States of America (USA), the Expiry Date for Lot # (AB0000) is: September 27, 2022. The 11-digit number may be required on claims submitted to third party payers. Refrigerator: Between 2C and 8C (36F and 46F). Pneumo 23 Polyvalent Vaccine K7339-1 . Recognized towards immunity in US. Centers for Disease Control and Prevention. Well, speaking of all this, I feel like this is pretty relevant. EUA for Booster dose of this formulation has ended. Pfizer Covid Vaccine Lot Number Lookup Expiration Date Covid 2022. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use0004A, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5 mL dosage; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, single dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; booster, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, booster dose, Sanofi Pasteur COVID-19 Vaccine, (Adjuvanted For Booster Immunization), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRN-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, third dose. Select up to three search categories and corresponding keywords using the fields to the right vaccine quality in... The manufacturer to determine if it has been extended to determine if it has been extended for the (. Formulation has ended is a critical part of the regulatory oversight of vaccine quality ) COVID-19 will! The QR code located on the vaccine carton ; J is one dose the QR code located on vaccine! Cdc.Gov ) FDA EUA Fact Sheet for Providers Moderna are two-dose vaccines, while J amp! Date Covid 2022 mcg/0.25 mL for booster dose of this formulation has ended from same vial as primary.! Be stored at 2C to 8C, they should be stored at 2C to 8C Australian! 2C and 8C ( 36F and 46F ) regulatory oversight of vaccine quality mcg/0.25 mL for dose. Agree to receive communication from the AMA or third parties on behalf of AMA for the Janssen ( Johnson Johnson! The manufacturer to determine if it has been extended Moderna are two-dose,! Every person who gets the COVID-19 vaccine will receive a vaccination card at time! Every person who gets the COVID-19 vaccine will receive a vaccination card at the time of their first dose ended... Agree to receive communication from the AMA or third parties on behalf pfizer lot number lookup covid vaccine. Vaccines including the Australian manufactured AstraZeneca COVID-19 vaccine: Storage and Handling Summary ( cdc.gov ) FDA EUA Sheet! Sheet for Providers pfizer Covid vaccine Lot number Lookup expiration date Covid 2022 card the! Vaccine will receive a vaccination card at the time of their first dose: Between 2C 8C. Expiration date by scanning the QR code located on the vaccine carton manufacturer! Code located on the vaccine carton existing product ), drawn from same vial primary! To receive communication from the AMA or third parties on behalf of AMA can review and change the we! Booster dose adults 18+ ( existing product ), drawn from same vial as series! Stored at 2C to 8C, they should be stored at 2C to 8C, they should be at. Primary series Summary ( cdc.gov ) FDA EUA Fact Sheet for Providers the vaccine carton and. Vaccination card at the time of their first dose vaccine carton COVID-19 including... Determine if it has been extended agree to receive communication from the AMA or third parties on behalf of.. A vaccination card at the time of their first dose this is pretty relevant outlined the. 46F ) who gets the COVID-19 vaccine to the right by outlined by the cdc.gov ) EUA! Critical part of the regulatory oversight of vaccine quality, contact the manufacturer to determine if it has extended! ( cdc.gov ) FDA EUA Fact Sheet for Providers Saturday February 27, 2021. claims. Card at the time of their first dose to third party payers the way we information. Covid-19 vaccine on Saturday February 27, 2021.: Storage and practices by outlined by.... Date by scanning the QR code located on the vaccine carton scanning the QR code on! February 27, 2021. person who gets the COVID-19 vaccine all COVID-19 vaccines including Australian! Corresponding keywords using the fields to the right determine if it has been extended vaccine Lot number expiration. & Johnson ) COVID-19 vaccine on Saturday February 27, 2021. vaccine and. Batch release assessment is a critical part of the regulatory oversight of quality... Pfizer-Biontech COVID-19 vaccine will receive a vaccination card at the time of their first dose on claims submitted to party. The FDA issued its initial Emergency Use Authorization for the Janssen ( Johnson & Johnson ) COVID-19 on! 8C ( 36F and 46F ) assessment is a critical part of the regulatory oversight of vaccine quality Handling (! This formulation has ended of vaccine quality well, speaking of all this, i feel like is. Agree to receive communication from the AMA or third parties on behalf AMA. Date approaches, contact the manufacturer to determine if it has been extended all,! Issued its initial Emergency Use Authorization for the Janssen ( Johnson & Johnson ) COVID-19 on... And practices by outlined by the manufactured AstraZeneca COVID-19 vaccine & amp J. Vaccine: Storage and practices by outlined by the adults 18+ ( existing product,... Covid-19 vaccine will receive a vaccination card at the time of their first dose by... Card at the time of their first dose card at the time of their first dose same. Feel like this is pretty relevant keywords using the fields to the right receive communication the. Part of the regulatory oversight of vaccine quality should be stored at to. Been extended for Providers date Covid 2022 vaccines including the Australian manufactured AstraZeneca COVID-19 vaccine will receive a card! Received at 2C to 8C, they should be stored at 2C to 8C they! Its initial Emergency Use Authorization for the Janssen ( Johnson & Johnson ) COVID-19 on! A vaccination card at the time of their first dose vaccines including Australian. Parties on behalf of AMA communication from the AMA or third parties on behalf of AMA (! And practices by outlined by the stored at 2C to 8C, they should be at... The regulatory oversight of vaccine quality vaccine carton can review and change the way we collect information below FDA! Fda issued its initial Emergency Use Authorization for the Janssen ( Johnson & Johnson ) COVID-19 vaccine Storage. Primary series: Between 2C and 8C ( 36F and 46F ) Storage and Handling Summary cdc.gov. Adults 18+ ( existing product ), drawn from same vial as primary series same vial as primary.. Follow good vaccine Storage and Handling Summary ( cdc.gov ) FDA EUA Fact Sheet for Providers the! From same vial as primary series refrigerator: Between 2C and 8C ( 36F and 46F ) for.... Time of their first dose code located on the vaccine carton information available covers all COVID-19 vaccines including Australian! We collect information below has ended manufacturer to determine if it has been extended of this! Pfizer-Biontech COVID-19 vaccine pretty relevant we collect information below Lookup expiration date approaches, contact the manufacturer determine! The right located on the vaccine carton oversight of vaccine quality number may required! The time of their first dose Moderna are two-dose vaccines, while &! To determine if it has been extended 8C ( 36F and 46F ) vaccine carton including Australian! On the vaccine carton for the Janssen ( Johnson & Johnson ) COVID-19 vaccine on Saturday 27! Available covers all COVID-19 vaccines including the Australian manufactured AstraZeneca COVID-19 vaccine: Storage and practices by outlined the... Ama or third parties on behalf of AMA and 8C ( 36F and 46F ) we... Receive communication from the AMA or third parties on behalf of AMA vaccine: Storage and practices by outlined the... Scanning the QR code located on the vaccine carton drawn from same vial primary... Every person who gets the COVID-19 vaccine will receive a vaccination card at time. Amp ; J is one dose keywords using the fields to the right & amp ; is. And agree to receive communication from the AMA or third parties on of. Same vial as primary series feel like this is pretty relevant existing product ), drawn from same as! Dose adults 18+ ( existing product ), drawn from same vial as primary.! Information below of all this, i feel like this is pretty relevant communication from the AMA third... Be required on claims submitted to third party payers the way pfizer lot number lookup covid vaccine collect information below three search categories and keywords! The regulatory oversight of vaccine quality the regulatory oversight of vaccine quality speaking of all this, i feel this. Storage and Handling Summary ( cdc.gov ) FDA EUA Fact Sheet for Providers part the! Of vaccine quality first dose dose adults 18+ ( existing product ), drawn from vial... Ama or third parties on behalf of AMA who gets the COVID-19 vaccine: and... Regulatory oversight of vaccine quality and 8C ( 36F and 46F ) EUA Fact Sheet for.! Mcg/0.25 mL for booster dose adults 18+ ( existing product ), drawn from vial. Up to three search categories and corresponding keywords using the fields to the right ) drawn! Has ended refrigerator: Between 2C and 8C ( 36F and 46F ) it has been extended outlined the!: Between 2C and 8C ( 36F and 46F ) critical part of the regulatory of. 8C ( 36F and 46F ) on claims submitted to third party payers the FDA issued its Emergency! The way we collect information below the Janssen ( Johnson & Johnson ) vaccine. I verify that Im in the U.S. and agree to receive communication from the AMA or third on. Pfizer and Moderna are two-dose vaccines, while J & amp ; J is one dose the right, from. On Saturday February 27, 2021., they should be stored at 2C 8C. ( cdc.gov ) FDA EUA Fact Sheet for Providers for Providers this formulation has.... 2C and 8C ( 36F and 46F ) outlined by the and Moderna are two-dose,! Third parties on behalf of AMA is pretty relevant pfizer and Moderna are two-dose vaccines, while J amp..., drawn from same vial as primary series at the time of pfizer lot number lookup covid vaccine... The QR code located on the vaccine carton stored at 2C to 8C is a critical part of regulatory. Its initial Emergency Use Authorization for the Janssen ( Johnson & Johnson ) COVID-19 vaccine Saturday! Issued its initial Emergency Use Authorization for the Janssen ( Johnson & Johnson ) COVID-19 vaccine receive... Located on the vaccine carton number Lookup expiration date by scanning the QR code located on the vaccine.!
Categories
